首页 > 最新文献

Journal of Vascular and Interventional Radiology最新文献

英文 中文
Feasibility of Robot-Assisted CT-Guided Interventions Compared with Conventional Technique: A Prospective, Randomized, Clinical Trial 与传统技术相比,机器人辅助计算机断层扫描引导的经皮介入治疗的可行性:一项前瞻性、随机、临床研究。
IF 2.6 3区 医学 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-03-01 Epub Date: 2025-11-25 DOI: 10.1016/j.jvir.2025.107925
Takafumi Sato MD , Tatsuya Kawai MD, PhD , Junichi Takikawa MS , Keita Nakayama MD, PhD , Shota Ohba MD, PhD , Masashi Shimohira MD, PhD , Kengo Ohta MD, PhD , Kazushi Suzuki MD, PhD , Shinji Kato MD , Yoshinao Ojio MD , Aki Hidari MD , Shunsuke Shibata MD, PhD , Masaya Kisohara MD , Misugi Urano MD, PhD , Takatsune Kawaguchi MD, PhD , Keisuke Hiroshima MD , Ryosuke Horino MD , Ka Wei Ng PhD , Siang Huei Leong PhD , Chow Wei Too MBBS, MMed , Akio Hiwatashi MD, PhD

Purpose

To investigate the feasibility of robot-assisted computed tomography (CT)–guided percutaneous needle placement compared with the conventional technique.

Materials and Methods

This single-center, open-label, randomized clinical trial included 70 patients with indications for CT-guided intervention, randomly assigned to conventional or robot-assisted groups. A table-mounted robotic system, automated needle-targeting device for CT, was utilized. Needle insertion time, technical success, diagnostic accuracy, procedure duration, needle angle adjustments, number of CT fluoroscopic acquisitions, radiation dose, and adverse event rates were compared.

Results

Seventy patients were enrolled, and 65 patients (33 robot-assisted) were analyzed. Lesion sizes were 44.3 mm (SD ± 26.7) and 43.0 mm (SD ± 28.4) in the conventional and robot-assisted groups, respectively (P = .845). There was no significant difference in the needle insertion time between the 2 groups (175.6 seconds [SD ± 211.8] vs 218.2 seconds [SD ± 242.1], P = .452). Technical success was 100% in both groups. Diagnostic accuracy was 87.0% in the conventional group and 93.3% in the and robot-assisted group (P = .671). Procedure duration was longer in the robot-assisted group (21.4 minutes [SD ± 5.6] vs 33.4 minutes [SD ± 10.3], P < .001). Needle adjustments (2.1 times [SD ± 1.8] vs 0.3 times [SD ± 0.7], P < .001), CT fluoroscopic acquisitions (10.0 times [SD ± 4.9] vs 7.7 times [SD ± 3.4], P = .027), and volume CT dose index (11.2 mGy [SD ± 5.9] vs 8.5 mGy [SD ± 4.7], P = .049) were lower in the robot-assisted group. Dose length product (667.4 mGy·cm [SD ± 247.2] vs 578.5 mGy·cm [SD ± 232.5], P = .143) and adverse event rates (28.1% vs 24.2%, P = .885) were not significant difference between groups.

Conclusions

The robotic system may allow accurate needle insertion across multiple sites, although with prolonged procedure time.
目的:探讨机器人辅助计算机断层扫描(CT)引导下经皮置针技术与传统置针技术的可行性。材料和方法:这项单中心、开放标签、随机临床试验包括70例具有ct引导干预适应症的患者,随机分配到常规组或机器人辅助组。采用台式机器人系统,CT自动针靶装置。我们比较了针头插入时间、技术成功率、诊断准确性、手术时间、针头角度调整、CT透视检查次数、辐射剂量和不良事件发生率。结果:纳入70例患者,分析65例患者(33例机器人辅助)。常规组和机器人辅助组病变大小分别为44.3±26.7 mm和43.0±28.4 mm (p = 0.845)。两组患者插针时间(175.6±211.8 s∶218.2±242.1 s; p = 0.452)差异无统计学意义。两组的技术成功率都是100%。常规组和机器人辅助组的诊断准确率分别为87.0%和93.3% (p = 0.671)。机器人辅助组的手术时间更长(21.4±5.6 vs 33.4±10.3 min; p < 0.001)。机器人辅助组的调针次数(2.1±1.8次vs. 0.3±0.7次,p < 0.001)、CT透视检查次数(10.0±4.9次vs. 7.7±3.4次,p = 0.027)和体积CT剂量指数(11.2±5.9次vs. 8.5±4.7 mGy, p = 0.049)较低。剂量长度乘积(667.4±247.2比578.5±232.5 mGy·cm, p = 0.143)和不良事件发生率(28.1%比24.2%,p = 0.885)组间差异无统计学意义。结论:虽然延长了手术时间,但机器人系统可以在多个部位精确插入针。
{"title":"Feasibility of Robot-Assisted CT-Guided Interventions Compared with Conventional Technique: A Prospective, Randomized, Clinical Trial","authors":"Takafumi Sato MD ,&nbsp;Tatsuya Kawai MD, PhD ,&nbsp;Junichi Takikawa MS ,&nbsp;Keita Nakayama MD, PhD ,&nbsp;Shota Ohba MD, PhD ,&nbsp;Masashi Shimohira MD, PhD ,&nbsp;Kengo Ohta MD, PhD ,&nbsp;Kazushi Suzuki MD, PhD ,&nbsp;Shinji Kato MD ,&nbsp;Yoshinao Ojio MD ,&nbsp;Aki Hidari MD ,&nbsp;Shunsuke Shibata MD, PhD ,&nbsp;Masaya Kisohara MD ,&nbsp;Misugi Urano MD, PhD ,&nbsp;Takatsune Kawaguchi MD, PhD ,&nbsp;Keisuke Hiroshima MD ,&nbsp;Ryosuke Horino MD ,&nbsp;Ka Wei Ng PhD ,&nbsp;Siang Huei Leong PhD ,&nbsp;Chow Wei Too MBBS, MMed ,&nbsp;Akio Hiwatashi MD, PhD","doi":"10.1016/j.jvir.2025.107925","DOIUrl":"10.1016/j.jvir.2025.107925","url":null,"abstract":"<div><h3>Purpose</h3><div>To investigate the feasibility of robot-assisted computed tomography (CT)–guided percutaneous needle placement compared with the conventional technique.</div></div><div><h3>Materials and Methods</h3><div>This single-center, open-label, randomized clinical trial included 70 patients with indications for CT-guided intervention, randomly assigned to conventional or robot-assisted groups. A table-mounted robotic system, automated needle-targeting device for CT, was utilized. Needle insertion time, technical success, diagnostic accuracy, procedure duration, needle angle adjustments, number of CT fluoroscopic acquisitions, radiation dose, and adverse event rates were compared.</div></div><div><h3>Results</h3><div>Seventy patients were enrolled, and 65 patients (33 robot-assisted) were analyzed. Lesion sizes were 44.3 mm (SD ± 26.7) and 43.0 mm (SD ± 28.4) in the conventional and robot-assisted groups, respectively (<em>P</em> = .845). There was no significant difference in the needle insertion time between the 2 groups (175.6 seconds [SD ± 211.8] vs 218.2 seconds [SD ± 242.1], <em>P</em> = .452). Technical success was 100% in both groups. Diagnostic accuracy was 87.0% in the conventional group and 93.3% in the and robot-assisted group (<em>P</em> = .671). Procedure duration was longer in the robot-assisted group (21.4 minutes [SD ± 5.6] vs 33.4 minutes [SD ± 10.3], <em>P</em> &lt; .001). Needle adjustments (2.1 times [SD ± 1.8] vs 0.3 times [SD ± 0.7], <em>P</em> &lt; .001), CT fluoroscopic acquisitions (10.0 times [SD ± 4.9] vs 7.7 times [SD ± 3.4], <em>P</em> = .027), and volume CT dose index (11.2 mGy [SD ± 5.9] vs 8.5 mGy [SD ± 4.7], <em>P</em> = .049) were lower in the robot-assisted group. Dose length product (667.4 mGy·cm [SD ± 247.2] vs 578.5 mGy·cm [SD ± 232.5], <em>P</em> = .143) and adverse event rates (28.1% vs 24.2%, <em>P</em> = .885) were not significant difference between groups.</div></div><div><h3>Conclusions</h3><div>The robotic system may allow accurate needle insertion across multiple sites, although with prolonged procedure time.</div></div>","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":"37 3","pages":"Article 107925"},"PeriodicalIF":2.6,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145641960","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of n-Butyl-2-Cyanoacrylate and Tris-Acryl Microspheres for Bronchial Artery Embolization in Patients with Cystic Fibrosis and Hemoptysis: A Retrospective Cohort Study 正丁基-2氰基丙烯酸酯微球和三丙烯酸酯微球用于囊性纤维化和咯血患者支气管动脉栓塞的比较:一项回顾性队列研究。
IF 2.6 3区 医学 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-03-01 Epub Date: 2025-12-13 DOI: 10.1016/j.jvir.2025.107959
Anna Maria Ierardi MD , Velio Ascenti MD , Andrea Gramegna MD, PhD , Francesco Blasi MD, PhD , Costantino Del Giudice MD , Genti Xhepa MD , Filippo Del Grande MD , Massimo Venturini MD, PhD , Gianpaolo Carrafiello MD, PhD , Andrea Coppola MD

Purpose

To compare the effectiveness and safety of bronchial artery embolization using n-butyl-2-cyanoacrylate (nBCA) versus tris-acryl microspheres in patients with cystic fibrosis.

Materials and Methods

Fifty-eight patients with severe hemoptysis (>100 mL/24 h) who underwent endovascular embolization between June 2019 and July 2024 were retrospectively analyzed. Patients were divided into 2 subgroups based on the embolic agent used: nBCA (n = 38) and tris-acryl microspheres (n = 20). Technical success, primary and secondary clinical success, safety, and recurrence rates were evaluated. Potential predictors of recurrence—including the number of pathological arteries identified on computed tomography (CT) angiography, the number and caliber of treated vessels, laterality, and embolized vascular district (bronchial vs nonbronchial systemic arteries)—were assessed using appropriate univariate tests.

Results

Technical success was achieved in all procedures. Primary clinical success was obtained in 57 of 58 patients (98.3%). During follow-up (mean, 42.9 months [SD ± 12.3]), recurrence occurred in 10 of 58 patients (17.2%), with a significantly higher relapse rate in the microsphere group (10 of 20, 50%) and no recurrences in the nBCA group (0 of 38) (P = .0005). Most recurrences (7 of 10) originated from nonbronchial systemic arteries previously embolized with microspheres. No major adverse events were observed. No other variable—including age, number of pathological arteries on CT angiography, vessel caliber, or laterality—showed a significant association with recurrence.

Conclusions

nBCA was associated with lower recurrence rates compared with tris-acryl microspheres. More relapses arose from nonbronchial systemic arteries. Further studies with larger cohorts are needed to confirm these findings and to evaluate additional factors influencing outcomes.
目的:比较囊性纤维化患者用正丁基-2-氰丙烯酸酯(NBCA)与三丙烯酸酯微球进行支气管动脉栓塞(BAE)的有效性和安全性。材料与方法:回顾性分析2019年6月至2024年7月行血管内栓塞治疗的重症咯血(>100 mL/24 h)患者58例。根据使用的栓塞剂将患者分为两组:NBCA (n = 38)和三丙烯酸酯微球(n = 20)。评估了技术成功、原发性和继发性临床成功、安全性和复发率。复发的潜在预测因素——包括CTA上发现的病理动脉数量、治疗血管的数量和口径、侧边性和栓塞血管区域(支气管与非支气管全身动脉)——使用适当的单变量测试进行评估。结果:所有手术均取得技术成功。58例患者中有57例(98.3%)获得初步临床成功。随访期间(平均42.9±12.3个月),10/58例患者出现复发(17.2%),其中微球组复发率(10/ 20,50 %)明显高于NBCA组(0/38)(p = 0.0005)。大多数复发(7/10)起源于先前用微球栓塞的非支气管全身动脉。未观察到重大不良事件。没有其他变量(包括年龄、CTA上病变动脉的数量、血管口径或侧边)显示与复发有显著关联。结论:与三丙烯酸酯微球相比,NBCA的复发率较低。更多的复发发生在非支气管全身动脉。需要更大规模的进一步研究来证实这些发现,并评估影响结果的其他因素。
{"title":"Comparison of n-Butyl-2-Cyanoacrylate and Tris-Acryl Microspheres for Bronchial Artery Embolization in Patients with Cystic Fibrosis and Hemoptysis: A Retrospective Cohort Study","authors":"Anna Maria Ierardi MD ,&nbsp;Velio Ascenti MD ,&nbsp;Andrea Gramegna MD, PhD ,&nbsp;Francesco Blasi MD, PhD ,&nbsp;Costantino Del Giudice MD ,&nbsp;Genti Xhepa MD ,&nbsp;Filippo Del Grande MD ,&nbsp;Massimo Venturini MD, PhD ,&nbsp;Gianpaolo Carrafiello MD, PhD ,&nbsp;Andrea Coppola MD","doi":"10.1016/j.jvir.2025.107959","DOIUrl":"10.1016/j.jvir.2025.107959","url":null,"abstract":"<div><h3>Purpose</h3><div>To compare the effectiveness and safety of bronchial artery embolization using <em>n</em>-butyl-2-cyanoacrylate (<em>n</em>BCA) versus tris-acryl microspheres in patients with cystic fibrosis.</div></div><div><h3>Materials and Methods</h3><div>Fifty-eight patients with severe hemoptysis (&gt;100 mL/24 h) who underwent endovascular embolization between June 2019 and July 2024 were retrospectively analyzed. Patients were divided into 2 subgroups based on the embolic agent used: <em>n</em>BCA (n = 38) and tris-acryl microspheres (n = 20). Technical success, primary and secondary clinical success, safety, and recurrence rates were evaluated. Potential predictors of recurrence—including the number of pathological arteries identified on computed tomography (CT) angiography, the number and caliber of treated vessels, laterality, and embolized vascular district (bronchial vs nonbronchial systemic arteries)—were assessed using appropriate univariate tests.</div></div><div><h3>Results</h3><div>Technical success was achieved in all procedures. Primary clinical success was obtained in 57 of 58 patients (98.3%). During follow-up (mean, 42.9 months [SD ± 12.3]), recurrence occurred in 10 of 58 patients (17.2%), with a significantly higher relapse rate in the microsphere group (10 of 20, 50%) and no recurrences in the <em>n</em>BCA group (0 of 38) (<em>P</em> = .0005). Most recurrences (7 of 10) originated from nonbronchial systemic arteries previously embolized with microspheres. No major adverse events were observed. No other variable—including age, number of pathological arteries on CT angiography, vessel caliber, or laterality—showed a significant association with recurrence.</div></div><div><h3>Conclusions</h3><div><em>n</em>BCA was associated with lower recurrence rates compared with tris-acryl microspheres. More relapses arose from nonbronchial systemic arteries. Further studies with larger cohorts are needed to confirm these findings and to evaluate additional factors influencing outcomes.</div></div>","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":"37 3","pages":"Article 107959"},"PeriodicalIF":2.6,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145758157","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Percutaneous Cryoablation of T1b Renal Tumors: A Retrospective Evaluation of Local Tumor Control, Renal Function Preservation, Adverse Events, and Ablation Margins in 80 Patients 经皮冷冻消融治疗T1b肾肿瘤:80例患者局部肿瘤控制、肾功能保存、不良事件和消融范围的回顾性评价
IF 2.6 3区 医学 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-03-01 Epub Date: 2025-09-20 DOI: 10.1016/j.jvir.2025.09.025
Antonios Michailidis MD , Panagiotis Kosmoliaptsis MD , Danae Makri MD , George Dimou MD , Evangelos N. Symeonidis MD , Andreas Andreou MD , Stylianos Tegos MD , Apostolos Papalakis MD , Panagiotis Mpalaksis MD , Georgios Moustakas MD , Christos Giankoulof MD , Evangelos Petsatodis MD, PhD

Purpose

To investigate whether achieving an intraprocedural ice-ball margin of ≥8 mm during percutaneous cryoablation (PCA) of T1b renal cell carcinoma (RCC) results in long-term local tumor control with acceptable adverse events profile.

Materials and Methods

Eighty consecutive patients with biopsy-proven T1b RCC (tumor size, 4.1–7.0 cm) were treated with computed tomography (CT)–guided PCA between 2019 and 2023 at a single center. Outcomes assessed included local tumor progression–free survival (LTPFS), change in renal function (estimated glomerular filtration rate [eGFR]), and adverse events per Society of Interventional Radiology (SIR) criteria. Ice-ball margins were categorized as <8 mm versus ≥8 mm. Kaplan-Meier survival curves and log-rank tests were used for statistical analysis, with significance set at P < .05.

Results

Primary effectiveness was 95% (76 of 80), while secondary effectiveness reached 98.8% (79 of 80) after retreatment of 4 local recurrences. The 24-month LTPFS was 98.8%. Patients with an ice-ball margin ≥8 mm showed a superior 24-month local control (100%) compared with those with 5 to <8 mm margins (57% at 6 months; P = .002). Mean eGFR declined slightly by −2 mL/min/1.73 m2 (P = .125). No SIR Grade 3 or higher adverse events were reported.

Conclusion

PCA is a safe, effective, and nephron-sparing treatment for T1b RCC. Achieving an ice-ball margin of ≥8 mm significantly reduces residual disease and early recurrence.
目的:本回顾性研究调查经皮冷冻消融(PCA)治疗临床T1b肾肿块(RMs)的长期疗效和安全性,至少随访两年。主要假设是,在T1b肾细胞癌(RCC)的PCA中实现≥8 mm的术中冰球边缘,可以在不增加不良事件的情况下获得更好的局部肿瘤控制。材料和方法:2019年至2023年,连续80例活检证实的T1b RCC(肿瘤大小4.1-7.0 cm)患者在单中心接受ct引导下的PCA治疗。评估的结果包括局部肿瘤无进展生存期(LTPFS)、肾功能改变(eGFR)和根据介入放射学会(SIR)标准的不良事件。结果:4例局部复发再治疗后,主要疗效为95%(76/80),次要疗效为98.8%(79/80)。24个月LTPFS为98.8%。与5-2的患者相比,冰球切缘≥8 mm的患者24个月的局部控制率(100%)更好(p = 0.125)。无SIR 3级或以上不良事件报告。结论:PCA是一种安全、有效、节约肾元的治疗方法。达到≥8mm的冰球切缘可显著减少疾病残留和早期复发。
{"title":"Percutaneous Cryoablation of T1b Renal Tumors: A Retrospective Evaluation of Local Tumor Control, Renal Function Preservation, Adverse Events, and Ablation Margins in 80 Patients","authors":"Antonios Michailidis MD ,&nbsp;Panagiotis Kosmoliaptsis MD ,&nbsp;Danae Makri MD ,&nbsp;George Dimou MD ,&nbsp;Evangelos N. Symeonidis MD ,&nbsp;Andreas Andreou MD ,&nbsp;Stylianos Tegos MD ,&nbsp;Apostolos Papalakis MD ,&nbsp;Panagiotis Mpalaksis MD ,&nbsp;Georgios Moustakas MD ,&nbsp;Christos Giankoulof MD ,&nbsp;Evangelos Petsatodis MD, PhD","doi":"10.1016/j.jvir.2025.09.025","DOIUrl":"10.1016/j.jvir.2025.09.025","url":null,"abstract":"<div><h3>Purpose</h3><div>To investigate whether achieving an intraprocedural ice-ball margin of ≥8 mm during percutaneous cryoablation (PCA) of T1b renal cell carcinoma (RCC) results in long-term local tumor control with acceptable adverse events profile.</div></div><div><h3>Materials and Methods</h3><div>Eighty consecutive patients with biopsy-proven T1b RCC (tumor size, 4.1–7.0 cm) were treated with computed tomography (CT)–guided PCA between 2019 and 2023 at a single center. Outcomes assessed included local tumor progression–free survival (LTPFS), change in renal function (estimated glomerular filtration rate [eGFR]), and adverse events per Society of Interventional Radiology (SIR) criteria. Ice-ball margins were categorized as &lt;8 mm versus ≥8 mm. Kaplan-Meier survival curves and log-rank tests were used for statistical analysis, with significance set at <em>P</em> &lt; .05.</div></div><div><h3>Results</h3><div>Primary effectiveness was 95% (76 of 80), while secondary effectiveness reached 98.8% (79 of 80) after retreatment of 4 local recurrences. The 24-month LTPFS was 98.8%. Patients with an ice-ball margin ≥8 mm showed a superior 24-month local control (100%) compared with those with 5 to &lt;8 mm margins (57% at 6 months; <em>P</em> = .002). Mean eGFR declined slightly by −2 mL/min/1.73 m<sup>2</sup> (<em>P</em> = .125). No SIR Grade 3 or higher adverse events were reported.</div></div><div><h3>Conclusion</h3><div>PCA is a safe, effective, and nephron-sparing treatment for T1b RCC. Achieving an ice-ball margin of ≥8 mm significantly reduces residual disease and early recurrence.</div></div>","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":"37 3","pages":"Article 107854"},"PeriodicalIF":2.6,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145126411","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Limb Graft Occlusion after Translumbar Glue Embolization of a Type II Endoleak II型内源性渗漏经腰椎内胶栓塞后肢体移植物闭塞。
IF 2.6 3区 医学 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-03-01 Epub Date: 2025-11-29 DOI: 10.1016/j.jvir.2025.107931
Geert Maleux MD, PhD, Hozan Mufty MD, PhD
{"title":"Limb Graft Occlusion after Translumbar Glue Embolization of a Type II Endoleak","authors":"Geert Maleux MD, PhD,&nbsp;Hozan Mufty MD, PhD","doi":"10.1016/j.jvir.2025.107931","DOIUrl":"10.1016/j.jvir.2025.107931","url":null,"abstract":"","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":"37 3","pages":"Article 107931"},"PeriodicalIF":2.6,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145649856","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cybersecurity for Interventional Radiologists: A Clinical Imperative for Protecting Patient Data and Imaging Systems 介入放射科医生的网络安全:保护患者数据和成像系统的临床必要性。
IF 2.6 3区 医学 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-03-01 Epub Date: 2025-11-19 DOI: 10.1016/j.jvir.2025.107920
Didier Jourdain BS
Cybersecurity threats to medical imaging systems and workflows are no longer confined to information technology departments; they directly affect interventional radiology (IR) practice, patient safety, and procedural continuity. Two thirds of healthcare organizations experienced ransomware in 2024, with median and mean ransom payments of 1.5 million and 4.4 million dollars, respectively, and 725 large breaches of protected health information were reported in the United States that year. Such incidents increasingly disrupt IR workflows, delay emergent and elective procedures, force patient diversion, and create downstream clinical risks. This review synthesizes data from national reports, peer-reviewed literature, and real-world case examples to highlight high-priority threats including ransomware, credential compromise, vendor and supply chain exposures, insecure Internet of Medical Things devices, and vulnerabilities associated with artificial intelligence tools and aligns them with practical mitigation strategies grounded in the National Institute of Standards and Technology Cybersecurity Framework. By engaging directly in cybersecurity governance, risk assessment, and downtime planning, IR physicians can help ensure resilient imaging infrastructure and safe adoption of emerging technologies, safeguarding patient care when it matters most.
医疗成像系统和工作流程的网络安全威胁不再局限于信息技术部门;它们直接影响介入放射学实践、患者安全和程序连续性。2024年,三分之二的医疗保健组织遭受了勒索软件攻击,赎金支付的中位数和平均值分别为150万美元和440万美元,当年美国报告了725起受保护的健康信息泄露事件。此类事件日益扰乱介入放射学工作流程,延误紧急和选择性手术,迫使患者转移,并造成下游临床风险。本综述综合了来自国家报告、同行评议文献和现实世界案例的数据,以突出高优先级威胁,包括勒索软件、凭证泄露、供应商和供应链风险、不安全的医疗物联网设备以及与人工智能工具相关的漏洞,并将其与基于国家标准与技术研究所网络安全框架的实际缓解策略保持一致。通过直接参与网络安全治理、风险评估和停机计划,介入放射科医生可以帮助确保弹性成像基础设施和新兴技术的安全采用,在最重要的时候保障患者护理。
{"title":"Cybersecurity for Interventional Radiologists: A Clinical Imperative for Protecting Patient Data and Imaging Systems","authors":"Didier Jourdain BS","doi":"10.1016/j.jvir.2025.107920","DOIUrl":"10.1016/j.jvir.2025.107920","url":null,"abstract":"<div><div>Cybersecurity threats to medical imaging systems and workflows are no longer confined to information technology departments; they directly affect interventional radiology (IR) practice, patient safety, and procedural continuity. Two thirds of healthcare organizations experienced ransomware in 2024, with median and mean ransom payments of 1.5 million and 4.4 million dollars, respectively, and 725 large breaches of protected health information were reported in the United States that year. Such incidents increasingly disrupt IR workflows, delay emergent and elective procedures, force patient diversion, and create downstream clinical risks. This review synthesizes data from national reports, peer-reviewed literature, and real-world case examples to highlight high-priority threats including ransomware, credential compromise, vendor and supply chain exposures, insecure Internet of Medical Things devices, and vulnerabilities associated with artificial intelligence tools and aligns them with practical mitigation strategies grounded in the National Institute of Standards and Technology Cybersecurity Framework. By engaging directly in cybersecurity governance, risk assessment, and downtime planning, IR physicians can help ensure resilient imaging infrastructure and safe adoption of emerging technologies, safeguarding patient care when it matters most.</div></div>","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":"37 3","pages":"Article 107920"},"PeriodicalIF":2.6,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145574827","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcomes and Risk Factors Following Tunneled Peritoneal Dialysis Catheter Insertion by Interventional Radiologists 介入放射科医师插入隧道式腹膜透析导管后的结果和危险因素。
IF 2.6 3区 医学 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-03-01 Epub Date: 2025-09-26 DOI: 10.1016/j.jvir.2025.09.031
Rithvik Karthikeyan MB, BCh, BAO , Ileesha Singh BS , Satvik Hadigal MD , Daniel Picus MD , Naganathan Mani MD

Purpose

To assess whether patient factors, including age, sex, and diabetic involvement, are associated with adverse events during the course of tunneled peritoneal dialysis (PD) catheter placed by interventional radiology (IR).

Materials and Methods

This retrospective cohort study examined patients (n = 104) who required kidney replacement and underwent their initial tunneled PD catheter insertion procedure by the IR team at an academic teaching hospital between July 2021 and May 2024. An adverse event during the course of PD was defined as the first episode of peritonitis, catheter dysfunction, catheter insufficiency, catheter intolerance, or death. Inferential analyses included logistic regression and Cox proportional-hazards models to assess potential risk factors.

Results

Of the included patients, 32 (30.8%) experienced at least 1 episode of peritonitis during their PD course, with 6 patients experiencing multiple episodes. Diabetic involvement had the highest hazard ratio of 1.59 (95% confidence interval, 0.92–2.75; P = .094), suggesting a potential association with the occurrence of adverse events. Staphylococcus infections appeared to be more common in late-onset peritonitis (P = .03).

Conclusions

Peritonitis remains a major adverse event of PD despite current best practices. Moreover, the differences in the causative organism based on the time of episode warrant further attention, especially in terms of its management and empiric antibiotics. Diabetic involvement also remains a significant risk for the occurrence of an adverse event in the course of the inserted catheter. A deeper understanding of the complexities associated with PD is essential to achieving better clinical outcomes.
目的:评估患者因素,包括年龄、性别和糖尿病患者是否与介入放射学放置隧道腹膜透析(PD)导管过程中的不良事件相关。材料和方法:本回顾性队列研究调查了2021年7月至2024年5月期间在一家学术教学医院的介入放射学团队进行的需要肾脏置换并首次行隧道PD导管置入手术的患者(n=104)。PD过程中的不良事件定义为首次腹膜炎、导管功能障碍、导管不全、导管不耐受或死亡。推断分析包括逻辑回归和Cox比例风险模型来评估潜在的危险因素。结果:在纳入的患者中,32例(30.8%)在PD病程中至少经历一次腹膜炎发作,其中6例经历多次发作。糖尿病患者的风险比最高,为1.59,CI 0.92-2.75, p =0.094,提示与不良事件的发生存在潜在关联。葡萄球菌感染在迟发性腹膜炎(LOP)中更为常见(p =0.03)。结论:腹膜炎仍然是腹膜透析的主要并发症,尽管目前的最佳做法。此外,基于发病时间的致病生物的差异值得进一步关注,特别是在其管理和经验性抗生素方面。糖尿病患者在导管插入过程中发生不良事件的风险也很大。更深入地了解PD的复杂性对于获得更好的临床结果至关重要。
{"title":"Outcomes and Risk Factors Following Tunneled Peritoneal Dialysis Catheter Insertion by Interventional Radiologists","authors":"Rithvik Karthikeyan MB, BCh, BAO ,&nbsp;Ileesha Singh BS ,&nbsp;Satvik Hadigal MD ,&nbsp;Daniel Picus MD ,&nbsp;Naganathan Mani MD","doi":"10.1016/j.jvir.2025.09.031","DOIUrl":"10.1016/j.jvir.2025.09.031","url":null,"abstract":"<div><h3>Purpose</h3><div>To assess whether patient factors, including age, sex, and diabetic involvement, are associated with adverse events during the course of tunneled peritoneal dialysis (PD) catheter placed by interventional radiology (IR).</div></div><div><h3>Materials and Methods</h3><div>This retrospective cohort study examined patients (n = 104) who required kidney replacement and underwent their initial tunneled PD catheter insertion procedure by the IR team at an academic teaching hospital between July 2021 and May 2024. An adverse event during the course of PD was defined as the first episode of peritonitis, catheter dysfunction, catheter insufficiency, catheter intolerance, or death. Inferential analyses included logistic regression and Cox proportional-hazards models to assess potential risk factors.</div></div><div><h3>Results</h3><div>Of the included patients, 32 (30.8%) experienced at least 1 episode of peritonitis during their PD course, with 6 patients experiencing multiple episodes. Diabetic involvement had the highest hazard ratio of 1.59 (95% confidence interval, 0.92–2.75; <em>P</em> = .094), suggesting a potential association with the occurrence of adverse events. Staphylococcus infections appeared to be more common in late-onset peritonitis (<em>P</em> = .03).</div></div><div><h3>Conclusions</h3><div>Peritonitis remains a major adverse event of PD despite current best practices. Moreover, the differences in the causative organism based on the time of episode warrant further attention, especially in terms of its management and empiric antibiotics. Diabetic involvement also remains a significant risk for the occurrence of an adverse event in the course of the inserted catheter. A deeper understanding of the complexities associated with PD is essential to achieving better clinical outcomes.</div></div>","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":"37 3","pages":"Article 107860"},"PeriodicalIF":2.6,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145187358","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute Lower Limb Ischemia from Stent-Graft Limb Compression after n-Butyl Cyanoacrylate–Ethiodized oil–Ethanol Mixture Sac Embolization for a Type II Endoleak 正丁基氰基丙烯酸酯-乙化油-乙醇混合物囊栓塞治疗II型内漏后支架-移植物肢体压迫引起的急性下肢缺血
IF 2.6 3区 医学 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-03-01 Epub Date: 2025-12-19 DOI: 10.1016/j.jvir.2025.09.029
Tatsuo Ueda MD, PhD, Ryutaro Fujitsuna MD, PhD, Hidemasa Saito MD, PhD, Misa Iwasaki MD, Hiromitsu Hayashi MD, PhD, Shin-ichiro Kumita MD, PhD
{"title":"Acute Lower Limb Ischemia from Stent-Graft Limb Compression after n-Butyl Cyanoacrylate–Ethiodized oil–Ethanol Mixture Sac Embolization for a Type II Endoleak","authors":"Tatsuo Ueda MD, PhD,&nbsp;Ryutaro Fujitsuna MD, PhD,&nbsp;Hidemasa Saito MD, PhD,&nbsp;Misa Iwasaki MD,&nbsp;Hiromitsu Hayashi MD, PhD,&nbsp;Shin-ichiro Kumita MD, PhD","doi":"10.1016/j.jvir.2025.09.029","DOIUrl":"10.1016/j.jvir.2025.09.029","url":null,"abstract":"","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":"37 3","pages":"Article 107858"},"PeriodicalIF":2.6,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145771912","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictors of Time-Dependent Ascites and Hydrothorax Response after Transjugular Intrahepatic Portosystemic Shunt Creation: A Claims Analysis 经颈静脉肝内门静脉系统分流术后时间依赖性腹水和胸水反应的预测因素:声明分析。
IF 2.6 3区 医学 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-03-01 Epub Date: 2025-09-26 DOI: 10.1016/j.jvir.2025.09.032
Austin J. Triana MD, MBA , Brian P. Triana MD, MBA , Charles Y. Kim MD , James Ronald MD, PhD

Purpose

To identify patient factors influencing the time-dependent response of ascites and hydrothorax after transjugular intrahepatic portosystemic shunt (TIPS) creation using a large claims data set.

Materials and Methods

Adult patients from a nationwide claims database with at least 4 paracenteses or thoracenteses within 60 days before TIPS and at least 30 days follow-up were included (paracentesis cohort, n = 3,742; diuretic subset, n = 1,110; thoracentesis cohort, n = 238). Continuous-time hidden Markov models were used to classify patients into underlying response states—nonresponse, partial response, and complete response (CR)—based on observed paracentesis, diuretic prescription, and thoracentesis claims. Transition intensities between response states were used to quantify how quickly patients responded to TIPS. Covariate effects influencing response time were estimated.

Results

In the paracentesis cohort, CR probabilities were 48%, 70%, and 88% at 90, 180, and 365 days post-TIPS, respectively. Male sex, metabolic dysfunction–associated steatohepatitis cirrhosis, and higher pre-TIPS paracentesis rates predicted slower freedom from paracenteses, whereas alcoholic cirrhosis predicted faster response. Among diuretic users, 38% achieved freedom from diuretics at 1 year; younger age and lower pre-TIPS dose predicted faster weaning. In the hydrothorax cohort, CR rates at 90, 180, and 365 days were 54%, 81%, and 94%. Higher pre-TIPS thoracentesis rates predicted slower response.

Conclusions

Although 88%–94% of patients no longer required paracenteses and thoracenteses within a year after TIPS creation, only half achieved CR by 90 days. The potentially protracted time course may help physicians to better counsel patients regarding expected outcomes after TIPS creation.
目的:利用大型索赔数据集确定影响TIPS术后腹水和胸水时间依赖性反应的患者因素。材料和方法:纳入了来自全国数据中心的成年患者,这些患者在TIPS实施前60天内至少有4个输卵管穿刺术或胸腔穿刺术,并进行了至少30天的随访(输卵管穿刺术组,n= 3742;利尿剂组,n= 1110;胸腔穿刺术组,n=238)。根据观察到的穿刺、利尿剂处方和胸腔穿刺要求,使用连续时间隐马尔可夫模型将患者分为潜在的反应状态——无反应、部分反应和完全反应(CR)。反应状态之间的过渡强度用于量化患者对TIPS的反应速度。估计影响反应时间的协变量效应。结果:在穿刺队列中,tips后90,180和365天的CR概率分别为48%,70%和88%。男性、代谢功能障碍相关的脂肪性肝炎肝硬化和tips穿刺前较高的穿刺率预示着穿刺解除较慢,而酒精性肝硬化预示着更快的反应。在利尿剂使用者中,38%的人在1年内不再使用利尿剂;年龄越小,tips前剂量越低,断奶速度越快。在胸腔积液队列中,90天、180天和365天的CR率分别为54%、81%和94%。tips前胸穿刺率越高,反应越慢。结论:对全国索赔数据的建模提供了TIPS后穿刺、利尿剂和胸穿刺需求变化的定量、随时间变化的估计,并确定了反应慢与快的预测因素。这些发现可能有助于医生更好地向患者咨询TIPS后的结果。
{"title":"Predictors of Time-Dependent Ascites and Hydrothorax Response after Transjugular Intrahepatic Portosystemic Shunt Creation: A Claims Analysis","authors":"Austin J. Triana MD, MBA ,&nbsp;Brian P. Triana MD, MBA ,&nbsp;Charles Y. Kim MD ,&nbsp;James Ronald MD, PhD","doi":"10.1016/j.jvir.2025.09.032","DOIUrl":"10.1016/j.jvir.2025.09.032","url":null,"abstract":"<div><h3>Purpose</h3><div>To identify patient factors influencing the time-dependent response of ascites and hydrothorax after transjugular intrahepatic portosystemic shunt (TIPS) creation using a large claims data set.</div></div><div><h3>Materials and Methods</h3><div>Adult patients from a nationwide claims database with at least 4 paracenteses or thoracenteses within 60 days before TIPS and at least 30 days follow-up were included (paracentesis cohort, n = 3,742; diuretic subset, n = 1,110; thoracentesis cohort, n = 238). Continuous-time hidden Markov models were used to classify patients into underlying response states—nonresponse, partial response, and complete response (CR)—based on observed paracentesis, diuretic prescription, and thoracentesis claims. Transition intensities between response states were used to quantify how quickly patients responded to TIPS. Covariate effects influencing response time were estimated.</div></div><div><h3>Results</h3><div>In the paracentesis cohort, CR probabilities were 48%, 70%, and 88% at 90, 180, and 365 days post-TIPS, respectively. Male sex, metabolic dysfunction–associated steatohepatitis cirrhosis, and higher pre-TIPS paracentesis rates predicted slower freedom from paracenteses, whereas alcoholic cirrhosis predicted faster response. Among diuretic users, 38% achieved freedom from diuretics at 1 year; younger age and lower pre-TIPS dose predicted faster weaning. In the hydrothorax cohort, CR rates at 90, 180, and 365 days were 54%, 81%, and 94%. Higher pre-TIPS thoracentesis rates predicted slower response.</div></div><div><h3>Conclusions</h3><div>Although 88%–94% of patients no longer required paracenteses and thoracenteses within a year after TIPS creation, only half achieved CR by 90 days. The potentially protracted time course may help physicians to better counsel patients regarding expected outcomes after TIPS creation.</div></div>","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":"37 3","pages":"Article 107861"},"PeriodicalIF":2.6,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145187328","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Drainage of Subphrenic Abscess with CT Fluoroscopy–Guided Z-Axis Puncture Technique 计算机断层透视引导下z轴穿刺技术引流膈下脓肿。
IF 2.6 3区 医学 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-03-01 Epub Date: 2025-09-12 DOI: 10.1016/j.jvir.2025.09.015
Hiroki Yoshikawa MD, Masashi Tamura MD, PhD, Jitsuro Tsukada MD, PhD, Yuji Furukawa MD, Masahiro Jinzaki MD, PhD, Seishi Nakatsuka MD, PhD
{"title":"Drainage of Subphrenic Abscess with CT Fluoroscopy–Guided Z-Axis Puncture Technique","authors":"Hiroki Yoshikawa MD,&nbsp;Masashi Tamura MD, PhD,&nbsp;Jitsuro Tsukada MD, PhD,&nbsp;Yuji Furukawa MD,&nbsp;Masahiro Jinzaki MD, PhD,&nbsp;Seishi Nakatsuka MD, PhD","doi":"10.1016/j.jvir.2025.09.015","DOIUrl":"10.1016/j.jvir.2025.09.015","url":null,"abstract":"","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":"37 3","pages":"Article 107843"},"PeriodicalIF":2.6,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145066364","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Histopathologic Response and Oncologic Outcomes after Transarterial Chemoembolization and Transarterial Radioembolization for Hepatocellular Carcinoma: Selection Bias and Suboptimal Technique Are Better Explanations 肝癌TACE和TARE后的组织病理反应和肿瘤预后:选择偏差和次优技术是更好的解释。
IF 2.6 3区 医学 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-03-01 Epub Date: 2025-09-18 DOI: 10.1016/j.jvir.2025.08.046
Sameer Bhatia MBBS, MS
{"title":"Histopathologic Response and Oncologic Outcomes after Transarterial Chemoembolization and Transarterial Radioembolization for Hepatocellular Carcinoma: Selection Bias and Suboptimal Technique Are Better Explanations","authors":"Sameer Bhatia MBBS, MS","doi":"10.1016/j.jvir.2025.08.046","DOIUrl":"10.1016/j.jvir.2025.08.046","url":null,"abstract":"","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":"37 3","pages":"Article 107851"},"PeriodicalIF":2.6,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145102844","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Vascular and Interventional Radiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1